Efficacy and safety of a first-in-class inhaled PDE3/4...

  • Main
  • 2019 / 6
  • Efficacy and safety of a first-in-class inhaled PDE3/4...
Pulmonary Pharmacology & Therapeutics 2019 / 6

Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma

Bjermer, Leif, Abbott-Banner, Katharine, Newman, Kenneth
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Pulmonary Pharmacology & Therapeutics
DOI:
10.1016/j.pupt.2019.101814
Date:
June, 2019
File:
PDF, 3.03 MB
2019
Conversion to is in progress
Conversion to is failed